Skip to main content

1 Result(s)

within Article Remove this filter Helen W. Wong Remove this filter Pharmacotherapy Remove this filter

and

  1. No Access

    Article

    Outcomes of Rituximab-abbs versus Rituximab in Patients with Diffuse Large B-Cell Lymphoma in a Noninferiority Study

    Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is one of the first line treatments for diffuse large B-cell lymphoma (DLBCL). Rituximab comprises most of the treatment cost ...

    Helen W. Wong, Vivian H. Nguyen, Timothy Y. Mok, Fang Niu, Merta Cushing… in BioDrugs (2024)